• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/41

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

41 Cards in this Set

  • Front
  • Back
adults over ___ should be screened every ___ for DM
45
3 years
DM is diagnosed if one of ___ (3) is present
2 FPG measurements >=126
1 FPG measurement >=200
GTT exceeds 200 within 2 h
initial DM2 drug regimen: ___
or ___, if obese
glipizide 5mg qd
metformin 500 mg qd
HbA1c should be measured every ___
goal is ___
6m
<7%
DM1 is ___% of DM
5-10%
glipizide is a ___ drug
sulfonylurea
T/F: urine glucose levels are important in screening
false
T/F: urine ketones levels are important in management
true
___% of DM2 pts are obese
80
recommended exercise regime:
aerobics ___ per week for ___ minutes
3--5
30--45
6 oral hypoglycemic families
sulfonulurea
a-glucosidase inhibitor
biguanide
non-sulfonylurea secretagogue
thiazolidinedione
DPP-4 inhibitor
metformin can cause ___ but this is rare
because of this, it's contraindicated in ___
lactic acidosis
renal failure
metformin causes less ___ than other hypoglycemic agents
weight gain
4 common metformin SEs
nausea
vomiting
diarrhea
metallic taste in mouth
1 a-glucosidase inhibitor
acarbose
2 TZDs
pioglitazone
rosiglitazone
___ must be monitored in pts taking TZDs
LFTs
LFT regime for TZD-taking patients (2)
every 2m for first year
periodically thereafter
DPP-4 inhibitors work via ___
inhibiting deactivation of incretin hormones
2 incretins
GLP-1
GIP (gastric inhibitory peptide)
1 DPP-4 inhibitor
sitagliptin
2 indications for insulin in DM2
in addition to oral hypoglycemics
as initial tx
insulin is indicated as initial tx for DM2 patients if ___
glucose >400
young, non-obese, symptomatic
___ insulin is good at controlling postprandial sugar
short-acting
long acting insulin is associated with low rates of ___ (2)
hypoglycemia
weight gain
3 rapid acting insulins
lispro
aspart
inhaled
rapid acting insulins have onset in ___ hrs,
peak at ___ hrs,
and act for ___ hrs
0.2--0.5
0.5--1
3--5
1 short-acting insulin
regular
short acting insulins have onset in ___ hrs,
peak at ___ hrs,
and act for ___ hrs
0.5--1
2--3
4--12
1 intermediate-acting insulin
NPH
intermediate acting insulins have onset in ___ hrs,
peak at ___ hrs,
and act for ___ hrs
1--2
4--5
10--20
2 long-acting insulins
glargine
detemir
long acting insulins have onset in ___ hrs,
peak at ___ hrs,
and act for ___ hrs
1--2
no peak
24
normal insulin regimen for DM1 pts:
either ___ or ___
split regimen
glargine + preprandial rapid-acting
split regimen means injections of ___ at ___ and ___
regular/NPH mix
before breakfast
before supper
2 non-insulin injectables
only ___ can be used in DM1
exenatide
pramlintide
pramlindtide
exenatide is a ___
it is indicated for ___
incretin mimetic
patients who failed metformin mono- or combination tx
pramlintide is a ___
it does ___
amylin analog
glucagon inhibition
appetite reduction
6 recommended values for DM pts
HbA1C<7%
80<FPG<120
BP<130/85
LDL<100
HDL>40
TAG<150
3 vaccines mandated for DM pts
flu
S. pneumoniae
tetanus
DM pts should get S. pneumoniae vaccine every ___
and tetanus every ___
5--7 years
10 years